Correction

Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients (vol 7, e551, 2017)

Journal

BLOOD CANCER JOURNAL
Volume 10, Issue 11, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41408-020-00374-3

Keywords

-

Ask authors/readers for more resources

A correction to this paper has been published and can be accessed via a link at the top of the paper.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available